Similar articles

• [The role of anorexigenics in the treatment of obesity].

  Laroche C, Boissonnas A. Laroche C, et al. Therapie. 1979 Mar-Apr;34(2):181-95. Therapie. 1979. PMID: 386556 Review. French. No abstract available.
• [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].

  Ortensio A, Avagnina S, Costantino A. Ortensio A, et al. Minerva Dietol Gastroenterol. 1988 Apr-Jun;34(2):109-16. Minerva Dietol Gastroenterol. 1988. PMID: 3050610 Review. Italian. No abstract available.
• [The treatment of obesity with the appetite curbing agent Mefenorex].

  Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G. Beyer G, et al. Med Welt. 1980 Feb;31(8):306-9. Med Welt. 1980. PMID: 7374423 German. No abstract available.
• Neuro-ophthalmologic observations in obesity during anorexigenic (Desopimon-EGYT) treatment.

  Takács L. Takács L. Ther Hung. 1974;22(4):176-9. Ther Hung. 1974. PMID: 4465962 No abstract available.
• Clinical aspects of the treatment of obesity by drugs: a review.

  Munro JF. Munro JF. Int J Obes. 1979;3(2):171-80. Int J Obes. 1979. PMID: 393645 Review.